APHP Bichat

Paris 13 trials 9 recruiting

13 Registered trials

9 Currently recruiting

Organisation

APHP Bichat

Location

Paris, France

Identifier

ORL-000002652

Address

46 Rue Henri Huchard, France

Departments

Cardiology
Diabétologie
Gastroenterology
Infectious Diseases
Médecine Interne
Néphrologie
Oncologie
Pneumology
Service d'oncologie thoracique
Service de Pneumologie

Clinical trials at this site (13)

Search interface

Evaluation of Glucocorticoids Plus Rituximab Compared to Glucocorticoids Plus Placebo for the Treatment of Patients With Newly-Diagnosed or … Pending

2024-516052-17-01 Patients with a diagnosis of IgAV according to Chapel H 10
Personnalized immunotherapy in patients with stage III non-small cell lung cancer Pending

2025-522801-39-00 Stage III Non Small Cell Lung Cancer 4
Trial assessing fianlimab plus cemiplimab plus chemotherapy or cemiplimab plus chemotherapy in patients with pleural mesothelioma Recruiting

2024-519208-29-00 Pleural mesothelioma 4 2026-04-02
Trial of Tepotinib compared to Standard Treatment in Patients with Advanced MET exon 14 Mutated Non-Small Cell Lung Cancer Recruiting

2024-519971-25-00 Advanced MET exon 14 Mutated Non-Small Cell Lung Cancer 5 2025-12-03
TOLEDDO: Effect of weekly GLP1 agonist treatment in "double diabetes": a randomized, open-label study Recruiting

2024-514906-30-00 "double diabetes" 5 2024-10-14
PRODIGE 70 - CIRCULATE - CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II Recruiting

2024-515297-27-00 colon carcinoma 5 2024-08-14
CARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA Recruiting

2023-503317-29-00 Metastatic renal cell carcinoma (mRCC) 5 2024-04-12
Personalized, CT-guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in n… Recruiting

2023-504637-42-01 aortic valve stenosis 6 2023-12-21
REVERT : REVErsing airway Remodelling with Tezepelumab Recruiting

2024-513195-18-00 Severe asthma 5 2023-03-27
A phase II-III randomized trial evaluating maintenance pembrolizumab (± pemetrexed) until progression versus observation (± pemetrexed) afte… Recruiting

2024-515945-40-00 Non small cell lung cancer 10 2022-05-02
Partial oral antibiotic treatment for bacterial brain abscess: An open-label randomised non-inferiority trial (ORAL) Recruiting

2023-505483-11-00 Brain abscess 6 2021-05-02
Phase III randomized trial of atezolizumab in elderly patients with advanced Non-Small-Cell Lung Cancer and receiving monthly carboplatin wi… Ended

2024-515946-17-00 Non Small Cell Lung Cancer 5 2019-07-22
Trial comparing the continuation of nivolumab and ipilimumab (doublet immunotherapy) to observation after a first 6 months treatment by nivo… Ended

2024-514586-20-01 Non small cell lung cancer 5 2018-05-02